El resugimeinto de los grampositovos: Razonnes significado cliniso y posibilidades de control

Revista Clinica Espanola

Volumn 197, Issue SUPPL. 2, 1997, Pages 3-11

  Garcia Rodriguez J A ^a   Garda Sanchez E ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866212312     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Bergogne-Berezin E. Nosocomia. infectons: new agents, incicence. prevention. Presse Med 1995; 24:89-97.
2. Eiros JM. Roctriguez Torres A. Infecciones en Unictades de Cuidados Intenslvos. En: Picazo JJ. Romero J eds. Conceptos actuaies en enfermeda des Intecciosas y microDiologia clinica. Barcelona: Ecicior.es Doyrna. S. A.. 1992; 59-76.
3. carvis WR. Edwards Jr B. Culver DH, et a.. Nosocomlal infection raie in adults and peclatric intensive core units in the United States. Am o Mec 1992: 91 (suppl):185-191.
4. Jarvis WR. Marione WJ. Predominant pa;nogens in hospital infections. J Ant.rr.icro;- Cnemore.ir 1992; 29 Jsupp- A): 19-24.
5. Maloney SA. Juras WR. Epidemic nosoco.nial pne.imor.ia :n the Intensive care uni:. Clin Chest Med i995; 16:209-223.'
6. Grupo de Trabao EPINE. Prevalencia de las infecciones nosocomiales en los nospi;ales espancles (EPiNE 1990 19941. En: Vaqué Ratart, ec. Sociedaci Espanoia de hiçiene y Meaiclna Preventive Hospl'.dlarias. 1995.
7. COCK DJ. Reeve BJ. Scnoles C. Mistamine-2 recGptor antagonists and antacic.s in tne critically i.l pop.tldtior: slress u.ceration versus nosocorr.ial pneumor.ia. Ir.tect Cor.tro. Hosp Eplcer 1991: 15-137-441.
8. Dahsmasn NS. Chowdhury MNH, hayed DF. Coaguiase negative staphyloccal bacteraemia with special reference to sep;ic shock: experience in an intensive care unit. J Infect 1994: 29:295-303.
9. Farr BM. Infection control in intensive care Units: modern problems, modern solutions. Curr Infect Opin Dis I993: 6:520-525.
10. George DL. Epiaemiotogy of nosocomial pneumonia in intensive care unit patients. Clin Cnest Med 1995: 16:29-44.
11. Grant Prentice H, Kibbler CC. Host defence effects and possible approaches to their correction in the bone-narrow transplant recipient Curr Opin Infeci Dis 1995: 8:229-233.
12. Moro ML, Vigano EF. Coxzi Lepri A. Risk lactors for central venous catheter-related infections in surgical and intensive care units. Infect Coniroi Hosp Epidemic, 1994; 15:253-264.
13. Riebet H, Haben B. Niterr.berg G. ei a. Prospective muiticenter study of vascular catheter related complications and risK factors for positive central catheter cultures in intensive cere unit patients. J Clin Microbiol 1990' 28:2.520-2.525.
14. Spencer RC. Epidemiology oi infection in ICU's. ir.t Care Med 1994; isuppl 4):S2-S6.
15. Vincent JL, Binari DJ. Suter ?M, et al. The prevalence of nosoc.omia, infection in intensive care units in Europe. Results of the Européen Prevalence of Infection in Intensive Care (EPIC)'Study. JAMA 1995: 274:639-644.
16. Bouza E, Maninez Beltrân J y Grupo de Trabajo para el Estudio ce Estafilococos. Estudio rr.ulticéntrico sobre ia prevalencia de cstafilococos en Espana. Enf Ir.tec Microbiol Clin 1988; 6:68-97.
17. Diaz Lopez MD. Sanchez-Carrillo C, Bouza E y Grupo de Trabajo para el Estudio de Estafilococos. Evoluciôn de la resistencia a antimicrobianos de Sfcp.hy'ucous aislados en hospitales espanoles. Rev Clin Esp 1994; 194:819-820.
18. Rodriguez-Cléixems M. Evoluciôn tie la resistencia a antimicrobianos de Staphalococciis aislados en hospitales espanoles. Enf Intec Microbiol Clin 1992;'lO(suppl3):24-29.
19. Romero Vivas J. Picazo de la Garza JJ. Infecclon nosocomiai por Staphylococcus aureus. En: Picazo JJ, Romero J. eds. Conceptos actuales en enfermedades infecciosas y microbiologia clinica. Infecciôn nosocomiai. Barcelona: Eciciones Doyma, S. A., 1992; 77-107.
20. Dahmash NS, Arora SC. Fayed DF. Chowdhury MNH. Infections in critically i,l patients: experience in MICU at a major teaching hospital. Infection 1994; 22:264-270.
21. O'Flare MD. Reynolds PE. Novel membrane proteins present in teicoplanin-resistant. vancomycin-sensitive, coagulase-negative. Staphy.'ococcus spp. J Antimicroo Chemother 1992; 30:753-768.
22. Coykencail AL. Classification and identification of tne viridlans streptococci. Ciln Microbiol Rev 1989; 2:315-328.
23. Kawamuva Y. Hou X-G. Sultana F, Miura H, Ezajj T. Determination of 16S rRNA sequences of Streptococcus mitt's ar.d Streptococcus godonlj and Phyloqenetic relationship among members of tne genus Streptococcus. Intern d System Bacteriol 1995; 45:406-408.
24. Ruoff KL. Dealing with viridans Streptococci in the Clinical Laboratory: the continuing challenge. Clin Microoiol News 1993; 15:73-76.
25. Naiman RA, Barrow JG. Penicillin-resistant bacteria in tne mouths and throats of children receiving continuous profilaxis against rhejma.ic fever. Ann Intern Med 1963; 58:768-772.
26. Bourgauit AM, Wilson VVR, Washington U JA. Antimicrobial susceptibilities of species of virkians streptococci. J iniect Dis 1979; 140:316-324.
27. Godîarb J, Wormser GP, Glaser JH. Meningitis caused by multiply antibiotic-resistant viridans streptococci, üPediatr 1984; 105:891-895.
28. Carratalâ J. Alcaide F, Fernandez-Sevilla A, Corbella X, Linares J, Gudioi F. Bacteriemia due to viridans streptococci that are highly resistant to Denicilt.n: increase among neutropenic patients with cancer. Clin Infect Dis 1995: 20:1.169-1.173. '
29. Doern GV. Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viriaans group Streptococci in :he United States. Antimicrob Agents Chemother 1996: 40:891-894.
30. Alcaide F, Linares J. Pallarés R, Carratalâ J. Benitez MA, Guoiol F. Martin R. In u:iro activities of 22 -lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 1995; 39:2.243-3.347.
31. Kaufhclcl A. Potgieter E. Cnromosomally mediated rncn-level genlamicin resistance in Streptococcus rnitis. Antimicrob Agents Chemother 1993: 37:2.740-2.742.
32. Farber BF. Eliopoulos GM, Ward Ji. Roufl K, Moeilering Jr RC. Mult.ply resistant viridans streptococci susceptibility to -lactam antibiotics and comparison of oeniciltin-binding protein patterns Antimicrob Agents Chemother 1983: 24:702-705.
33. Carratala J. Gaciol F. Lite-threatening infections due to penicillin-resistant viridans streptococci. Curr Opin Infect Dis 1995; 8:123-126.
34. Sâr.cnez R. Muiîcz P. Rocnguez-Créixerns M, Pelàez T. Vasalo F,j, Bouza E. Susceptibility pattern of Streptococcus viridans group isolated from blood cultures ;abstmct E-5). In: The 34th Interscience Conference on Antimicrobial Agents and Cnemotherapy 1994; Washington, DC: American Society for Microoioiogy.
35. Alcaide F. Linares J, Ayats J. et al. /n ut'ro activity of 17 lac tarn antibiotics against viridans streptococci isoiatec trom blooct (aostrac1. 1017;. in: Program of the 6th European Congress of Clinical Microbiolcgy and infectious Diseases. 1993. European Society ot Clinica Microbiology and Infectious Diseases.
36. Märtinez Betran J, i_oza E, Aimaruz r, Sierra M.P. Canton R. Baquero F. The c.n;irnicrobial susceptibi.ity pattern o: Streptococcus rnitis ana Strep-rococcus pneumonias: resemblances and clearances (abstract E-13). Abs:racts ot the 34tn Interscience Conference on Antimicrobial Agents and Chetnotnerapy 1994: Washington. DC: Amencan Society for Microbiology.
37. Poigititer E, Carmichael M, Koornhof HJ, Chalkiey LJ. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbio, Inîec: Dis 1992: 11:543-546.
38. Vvilcox MH, W:nstar,ey TG Douglas CVvI, Spencer RC. Susceptibility of alfa-hameolytic streptococci causing endocarditis to benzylpenicillin and en cephaiosoonns. J Antimicrob Chernother 1993: 32:63-69.
39. McWhirres, PHM, Patei S. Whiley FIA, Hardie JM, Gülespie SH, Kibbler CC. Activities of potential therapeutic ana prophylactic antioiotics against blood culture isolates cf vir.aans group streptococci from neutropenic -Datients receiving ciprofioxacin. Antimicrob Agents Chemother 1993; 37:2.493-2.495.
40. Berenguer J. Infecc.ones por bacterias grampositivas en pacientes neutropénicos. Rev Clin Esp 1994; 194 Jsuppl 4):S62-865.
41. Dowson CG, Hutchinson A, Woodforc N, Johnson AP, George RC, Spratt BG. Penicillin-resistant viricians streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Sireptococcus pneumoniae. Proc Natl Acac Sei USA 1990; 87:5.858-5.862.
42. Quinr. JP, DiVicenzo CA. Lucks DA, Lus.-,in RL, Shatzer KL, Lerner SA. Serious infections due to penicillin-resistant strains of viridans streptococc. with altered penicillin-binding proteins. J Infect Dis 1988; 157:764769.
43. Nationa. Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 6th International Supplement M100-S6. Villanova PA. NCCLS, 1995.
44. Bochad PY, Eggiman Ph, Calandra Th, Van Mel.e G, Saghaf. L, Francioii P. Bacteriemia ciue to viridans Streptococcus in neutropenic patients with cancer. Ciinical spectrum and risk factors. Clin Infect Dis 1994; 18:25 31.
45. Phillips I, Warren C. Harrison JM, Sharpies P. Bail LC. Parker MT. Antibiotic susceptibilities of streptococci from the mouth and blood of patients treated with penicillin or lincomydn and clindarnycin. Meci Microbiol 1976; 9:393-403.
46. Guiot HFL, Corel LJA, Voosen JMJJ. Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haemaiological disorders. Eur J Cln Microbiol Infect Dis 1994; 13:645-650.
47. Fenoll A, Martin-Bourgon C. Munoz R, Vicioso D, Casai J. Serotype, distribution and antimicrobio, resistance in Streptococcus pneumoniae isolates producing systemic infections in Spain 1979-1989. Rev Infect Dis 1991; 13:56-60.
48. Linares J, Pérez JL. Garau J, Martin R. Cotnmoxazole resistance in Pneumococci. Eur J Clin Microbiol 1983; 2:473-474.
49. Eriksen KS. Studies on induced resistance to penicillin in a pneumococcus type 1. Acta Pathologica et Microbiologica Scandinavica 1945; 22:398-405.
50. Mckee CM. Houck CL. Inducec resistance to penicillin of cultures of Staphylococci. pneumococci and Streptococci. Proc Soc Exp Biol Mec 1943;' 53:33-34.
51. Schmidt LH, Serler CL. Development of resistance to penicillin by pneumococci. Proc Soc Exp Biol Med 1943; 53:353-357.
52. Flansman D. Bullen MM. A resistant pneumococcus. Lancet 1967; 2:264-265.
53. Appe.baum PC, Bhamjee A, Scraag JN, Hailett Ad, Bowen AF, Cooper RC. Streptococcus pneumoniae resistant a penicillin and chloranienicoi. Lancet 1977; 2:995-997.
54. Jacobs MR. Koornhof HJ, Robins-Browne RM, et a,. Emergence of mjitiply-resistant pneumococci. New Eng J Mec 1978; 299:735-740.
55. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3:171-196.
56. Linares J. Antiolotic resistant pneumococci in the 1990s: an overview in Spain in Streptococcus pneumoniae. Molecular Biology and Mechanisms of Disease-Update for the 1990s. Oeiras. Portugal, 1996.
57. Zighelboim S, Tomasz A. Penicillin-binding protein of muiuply antibiotic-resistant South Africa strains of Streptococcus pneumoniae Antimicrob Agents Chemother 1980; 17:434-442.
58. iJowson CG. Hutchinson A, Spratt BG. Extensive re-modeling o: the transpepticlase domain of penicillin-binding protein 2B of a penicillin-resistant South African Isolate of Streptococcus pneumoniae Mol Microbioi 1989; 3:95-102.
59. Dowson CG. Hutchinson A, Brannigan JA, e: al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneurnoniae. Proc Natl Acad Sei USA 1989; 86:8.8428.846.
60. Munoz R, Dowson CG, Daniels M. CoHyy JL, Martin C. Hokenbeck R, Spratt BG. Genetic of resistance to third-generation cephalosponns in clinical isolates of Streptococcus pneumonias. Mol Microbiol 1992; 0:2.4612.465.
61. Hakenoecd R. Tarpay M. Tomasz A. Multiple changes of penici.lin-binding proteins in par,ici,Sin-resistant clinical isolates of Streptococcus pneumococci. Antimicrob Agents Chemother 1980; 17:364-371.
62. Smitn AM, K.ugman KP. Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneurnoniae. Antimicrob Agents Chemotner 1995; 39:859-867.
63. Coftey I J. Daniels M. McDouoai i_K. Dowson CG, Tenover FC, Spratt BC. Genetic analysis of c.inicai isolates :'o Streptococcus pnejrnoniae with n.ch ,evel "esistant to expanded-spectrurn cepha.osoorins. Antimicrob Agents Chemother 1995'39:1.306-1.313.
64. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to -lactams antibiotics. Pediatr Infect Dis J 1991; 10:871-873.
65. Friecland IR, Shelton S, Paris M, et ai. Dilemans in diagnosis and management cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect'Dis 1993; 12:196-200.
66. Marion A. Epidemiology of resistant pneumococci in Hungary. Microbial Drug Resistance 1995; 1:125-130.
67. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumo nice. An overview. Ginical Infectious Diseases 1992; 15:77-83.
68. Nava JM, Bella F, Garau J, et aï. Predictive iactors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a populations based study. Clin Infect Dis 1994: 19:884-890.
69. Ferez JL. Linares J, Bosch J. Antibiotic resistance of Streptococcus pneumoniae in childhood carriers. J Aniimicrob Chemother 1987; 19:278-280. 70 Reeves RR. Jones JA. Antibiotic use and resistance: patterns in day care centers. Semm Pediatr Infect Dis 1990; 1:212-221.
70. Thacker SB, Adis DG, Goodman RA, Hoilowan BR, Spences GC. Infectious diseases and injuries in child day care: opportunities for healthier children. JAMA 1992: 208:1.720-1.726.
71. Pallarés R. Gudloi F Linares J. et al. Risk tactors an response to antibiotic therapy in adults with bacteremia pneumonia caused by penicillin-resistant pneumococci. N Engl j Med 1987; 317:18-22.
72. Negri MC, Morosini MI, Loza E, Baquero F. In vitro selective concentration of -lactams for penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1994; 38:122-125.
73. Bouza E, Munoz P. Penicillin resistant pneumococci in adult disease with special reference to AIDS patients. Microbial Drug Resistance 1995; 1:9-28.
74. Jacobs MR, Appelbaum PC. Antibiotics-resistant pneumococci. Rev Med Microbiol 1995; 6:7.793.
75. Horodiceanu T. Bougueiet L, Bieth G. Conjugative transfer of multipleantibiotic resistance markers in p-h.emolytic group A, B, F and G streptococci in the abscence of extracromosomal deoxyribonucleic acid. Plasmid 1981; 5:127 137.
76. ubukata K, Konno M, Fuji R. Transduction of drug resistance to tetracycline, chloramphenicol, lincomycin and dindamycin with phage induced from Streptococcus pyogenes. J Antibiot 1980; 18:629-637.
77. Tomasz A. Penicillin-binding proteins the antibacterial effectiveness of p-lactam antibiotics. Rev Infect Dis 1986; 8 (suppl 3):S260-S278.
78. Severin MJ, Wiley JL. Change in susceptibility of group B streptococci to penicillin G from 1968 through 1975. Antimicrob Agents and Chemother 1976; 10:380-381.
79. Betriu C, Gômez M, Sânchez A, Cruceyra A, Romero J, Picazo JJ. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 1994; 38:2.183-2.186.
80. Jones RN, Kehrber EN, Erwin ME, Anderson SC, and the Fluoroquinolone Resistance Surveillance Group. Prevalence of important pathogens and antimicrobial activity of parenteral centers in the United States. Diagn Microbiol Infect Dis 1994; 19:203-215.
81. Schaberg DR, Culver DH, Gayner RP. Mator trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (suppl 3B;:72S-75S.
82. Moeliering RC Jr. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 1992; 14:1.173-1.178.
83. Chenoweth C. Schaberg D. The epidemiology of enterococci. Eur J Clin Microbioi infect Dis 1990; 9:80-39.
84. Körten V, Murray BE. The nosocomial transmissions of enterococci. Curr Opin Infect Dis 1993; 6:498-505.
85. Hall LMC. Recent advances in understanding the epidemiology of enterococci. Rev Med Microbioi 1993; 4:192-197.
86. Facklarr. RR, Collins MD. identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbioi 1989; 27:731-734.
87. Ruoff KL, De la Maza L, Murtagh MJ. Spargo JD, Ferraro Mj. Species identifies of enterococci isolated from clinical specimens. J Cm Microbioi 1990; 28:535-537.
88. Coliins MD, Fackiam RR, Farrow JAE, Wi.liamson R. Enferococcus raf/lnosus spp. nov. Enterococcus so/iran'us spp. nov. and Enterococcus pseudoaviurn spp. nov. FEMS. Microbioi Lett 19S9; 57:283-288.
89. Collins MD, Rodrigues UM, Pigott NE, Fackiam RR. Enrerococcus dispcr spp. nov., a new Enterococcus from human sources. Lett Appl Microbioi 1991; 12:95-98.
90. Pompei R, Bsriutti F, Thaller MC, Ingianni A, Cortis G, DameU B. Enierococcits f'ciuescens spp. nov., a new species of enterococci ol clinical origin. lnt J Sysi Bacteriol 1992; 42:365-369.
91. Moellaring RC Jr. The Enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 1991; 28:1-12.
92. King A, Phillips I. Reporting in vitro activity of new antimicrobial agents. J Antimicrob Chemother 1995; 35:227-238.
93. Yague G. Cémara M, Gömez C, et al. Sensibilidad in vitro de aislamientos ciinicos de Enterococcus spp. a varios antibiottcos. Rev Esp Quimioter 1994; 7:309-312.
94. McClean KL, Shoehan GJ, Harding GKM. Intraabdominal infection: a review. Clin Infect Dis 1994; 19:100-116.
95. Collins LA, Malanoski GJ. Eliopoulos GM. In ultra activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother 1993; 37:598-601.
96. Montravers P, Andremnt A, Massias L, Carbon C. Investigation of the potential role of Enterococcus faecalis in the paîhophysioiogy of experimental peritonitis. J Infect Dis 1994; 169:821-830.
97. Cherubin CE, Appfeman MD, Heseltine PN, Hhayr W, Stratton CW. Epidemioloaicai spectrum and current treatment of listeriosis. Rev Infect Dis 1991; 13:1.108-1.114.
98. Moreno Guillén S. Infecciones por grampositivos en los pacientes con infection por el virus de la inmunodeficiencia humana. Rev Clin Esp 1994: 194 (suppl 4):866-869.
99. Bouza E. infection causada por Clostridium difficile. Situacion en los 90. Rev Clin Esp 1994; 194 ïsuppi 4):870-877.
100. Garcia-Rodriguez JA, Garcia Sânchez JE, Garcia MI, Tmjillano L Infecciones nosocomiales por anaerobios. Enferm Infecc Microbioi Clin 1995; 13:429-434.